Breaking News

Chimeron Bio Selects Mfg. Partner FUJIFILM Diosynth Biotechnologies

To scale up drug substance manufacturing process at cGMP manufacturing facility in College Station, TX for IND-enabling work.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Chimeron Bio, an RNA company developing self-amplifying RNA (saRNA) vaccines and therapeutics, has entered into a manufacturing agreement with FUJIFILM Diosynth Biotechnologies (FDB), a CDMO with experience in the development and manufacture of recombinant biopharmaceuticals and viral gene therapies, to advance Chimeron Bio’s oncology portfolio to the clinic.   Chimeron Bio selected FUJIFILM Diosynth Biotechnologies as its partner for the transfer and scale up of their drug substance manufactu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters